Chemoinformaics analysis of Glyceryl 1,3-distearate
| Molecular Weight | 625.032 | nRot | 36 |
| Heavy Atom Molecular Weight | 548.424 | nRig | 11 |
| Exact Molecular Weight | 624.569 | nRing | 0 |
| Solubility: LogS | -4.612 | nHRing | 0 |
| Solubility: LogP | 4.311 | No. of Aliphatic Rings | 0 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 120 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 44 | No. of Aromatic Carbocycles | 0 |
| nHetero | 5 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 76 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 39 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 5 | No. of Arom Bond | 0 |
| nHA | 5 | APOL | 119.816 |
| nHD | 1 | BPOL | 81.4517 |
| QED | 0.572 |
| Synth | 3.767 |
| Natural Product Likeliness | 1.321 |
| NR-PPAR-gamma | 0.004 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.998 |
| Pgp-sub | 0.134 |
| HIA | 0.006 |
| CACO-2 | -4.828 |
| MDCK | 0.0000154 |
| BBB | 0.052 |
| PPB | 0.905221 |
| VDSS | 2.514 |
| FU | 0.0998327 |
| CYP1A2-inh | 0.956 |
| CYP1A2-sub | 0.88 |
| CYP2c19-inh | 0.762 |
| CYP2c19-sub | 0.583 |
| CYP2c9-inh | 0.486 |
| CYP2c9-sub | 0.475 |
| CYP2d6-inh | 0.959 |
| CYP2d6-sub | 0.789 |
| CYP3a4-inh | 0.244 |
| CYP3a4-sub | 0.453 |
| CL | 5.274 |
| T12 | 0.751 |
| hERG | 0.354 |
| Ames | 0.014 |
| ROA | 0.071 |
| SkinSen | 0.964 |
| Carcinogencity | 0.505 |
| EI | 0.052 |
| Respiratory | 0.876 |
| NR-Aromatase | 0.039 |
| Antiviral | No |
| Prediction | 0.618265 |